Paper21397057
Inorganic polymeric phosphate/polyphosphate as an inducer of alkaline phosphatase and a modulator of intracellular Ca2+ level in osteoblasts (SaOS-2 cells) in vitro.
Müller WE and 8 others. Acta Biomater, 2011. Cited by 110 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Inorganic polymeric phosphate/polyphosphate as an inducer of alkaline phosphatase and a modulator of intracellular Ca2+ level in osteoblasts (SaOS-2 cells) in vitro. Papers, record 21397057. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21397057
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Inorganic polymeric phosphate/polyphosphate as an inducer of alkaline phosphatase and a modulator of intracellular Ca2+ level in osteoblasts (SaOS-2 cells) in vitro.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Alkaline Phosphatase | Major topic |
| Calcium | Major topic |
| Osteoblasts | Major topic |
| Phosphates | Major topic |
| Cell Line | |
| Enzyme Induction | |
| Humans | |
| Immunohistochemistry | |
| Microscopy, Electron, Scanning | |
| Reverse Transcriptase Polymerase Chain Reaction | |
| Signal Transduction |
Source PubMed
Cited by47
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 110 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,629,587 | Mitigation of serotonin-caused suppression of osteoblast function by extracts of the psychoactive indigenous plant Sceletium tortuosum. | BMC Complement Med Ther | 2026 | https://conductscience.org/library/papers/42629587 | PubMed |
| 42,084,033 | A GMP-compliant formulation of regeneratively active polyphosphate for wound healing and skin regeneration. | Biomater Sci | 2026 | https://conductscience.org/library/papers/42084033 | PubMed |
| 42,029,947 | 3D-printed PCL scaffolds: optimising material selection for specific bone regeneration applications. | J Mater Sci Mater Med | 2026 | https://conductscience.org/library/papers/42029947 | PubMed |
| 41,733,679 | Inorganic Polyphosphate and Alkaline Phosphatase/Adenylate Kinase: Key Components of the Physiological ATP-Dependent Wound Repair and Mode of Action. | Prog Mol Subcell Biol | 2026 | https://conductscience.org/library/papers/41733679 | PubMed |
| 41,495,292 | Calcium ions play a critical role in calcification of Corynebacterium matruchotii. | Sci Rep | 2026 | https://conductscience.org/library/papers/41495292 | PubMed |
| 41,040,413 | Biosynthetic polyphosphate enhances osteogenesis of human periodontal ligament stem cells and promotes periodontal bone regeneration in a murine periodontal bone defect model. | Front Bioeng Biotechnol | 2025 | https://conductscience.org/library/papers/41040413 | PubMed |
| 39,267,793 | Energy level as a theranostic factor for successful therapy of tissue injuries with polyphosphate: the triad metabolic energy - mechanical energy - heat. | Theranostics | 2024 | https://conductscience.org/library/papers/39267793 | PubMed |
| 38,348,175 | The Physiological Inorganic Polymers Biosilica and Polyphosphate as Key Drivers for Biomedical Materials in Regenerative Nanomedicine. | Int J Nanomedicine | 2024 | https://conductscience.org/library/papers/38348175 | PubMed |
| 38,256,081 | Effects of Daidzein, Tempeh, and a Probiotic Digested in an Artificial Gastrointestinal Tract on Calcium Deposition in Human Osteoblast-like Saos-2 Cells. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38256081 | PubMed |
| 36,474,526 | Inorganic Polyphosphate: Coacervate Formation and Functional Significance in Nanomedical Applications. | Int J Nanomedicine | 2022 | https://conductscience.org/library/papers/36474526 | PubMed |
| 36,065,353 | Functional importance of coacervation to convert calcium polyphosphate nanoparticles into the physiologically active state. | Mater Today Bio | 2022 | https://conductscience.org/library/papers/36065353 | PubMed |
| 35,697,938 | Biomimetic Polyphosphate Materials: Toward Application in Regenerative Medicine. | Prog Mol Subcell Biol | 2022 | https://conductscience.org/library/papers/35697938 | PubMed |
| 35,697,937 | Polyphosphate in Chronic Wound Healing: Restoration of Impaired Metabolic Energy State. | Prog Mol Subcell Biol | 2022 | https://conductscience.org/library/papers/35697937 | PubMed |
| 35,697,936 | Inorganic Polyphosphate, Mitochondria, and Neurodegeneration. | Prog Mol Subcell Biol | 2022 | https://conductscience.org/library/papers/35697936 | PubMed |
| 35,519,495 | Utilization of metabolic energy in treatment of ocular surface disorders: polyphosphate as an energy source for corneal epithelial cell proliferation. | RSC Adv | 2019 | https://conductscience.org/library/papers/35519495 | PubMed |
| 35,457,055 | Calcined Hydroxyapatite with Collagen I Foam Promotes Human MSC Osteogenic Differentiation. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35457055 | PubMed |
| 35,327,460 | Inorganic Polymeric Materials for Injured Tissue Repair: Biocatalytic Formation and Exploitation. | Biomedicines | 2022 | https://conductscience.org/library/papers/35327460 | PubMed |
| 35,279,778 | Synergistic effect of cell and molecule - imprinted substrates for bone tissue engineering. | Mol Biol Rep | 2022 | https://conductscience.org/library/papers/35279778 | PubMed |
| 34,749,808 | Safety and feasibility study of using polyphosphate (PolyP) in alveolar cleft repair: a pilot study. | Pilot Feasibility Stud | 2021 | https://conductscience.org/library/papers/34749808 | PubMed |
| 34,127,045 | Polyphosphate (PolyP) for alveolar cleft repair: study protocol for a pilot randomized controlled trial. | Trials | 2021 | https://conductscience.org/library/papers/34127045 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/21397057
GET https://conductscience.org/api/papers/v1/21397057/cited_by?page=2